CHANGE OF CONGENITAL IMMUNITY FACTORS IN CHILDREN WITH CYSTIC FIBROSIS


Cite item

Full Text

Abstract

The aim of the study was to determine the key factors of innate immunity in the 118 children with cystic fibrosis. In patients with CF identified pronounced changes in the indices of innate immunity, both in serum and at the level of the mucous membrane. In chronic sowing of the bronchial tree, Pseudomonas aeruginosa and/or Staphylococcus aureus levels of bactericidal and lysozyme activity of blood serum, C5a component of complement can be considered as markers of inflammation and provide additional laboratory diagnostic criteria of bronchopulmonary phase of the process. In acute bronchopulmonary process in children with Burkholderia cepacia observed anergy factors of innate immunity, which dramatically increases the risk of septic complications.

References

  1. Капранов Н.И., Каширская Н.Ю., Воронкова А.Ю. Муковисцидоз: современные достижения и актуальные проблемы. М., 2008. 104 с.
  2. Певницкий Л.А., Пухальский А.Л., Капранов Н.И.. Иммунологический мониторинг больных муковисцидозом. Значение различных лабораторных показателей // Вестник РАМН. 2000. № 5. C. 40-46.
  3. Пухальский А.Л., Шмарина Г.В., Пухальская Д.Д. Особенности воспалительного процесса у больных муковисцидозом // Пульмонология. 2006. Приложение. С. 81-83.
  4. Никулина Б.А. Иммунологический статус и методы его оценки. М., 2008. 457 с.
  5. Berger M, Sorensen R, Tosi M, et al. Complement receptor exspression on neutrophils at an inflammatory site the pseudomonas-infected lung in cystic fibrosis. Clin Invest 1989;84(1):1303-12.
  6. Huhn R, Pennline K, Radwanski E. Effects of single intravenous doses of recombinant human interleukin-10 on subsets of circulating leukocytes in humans. Immunopharmacology 1999;41(4):109-17.
  7. Koch C. Early infection and progression of Cystic Fibrosis Lung Disease. Pediatric Pulmonology 2002;34(3):232-36.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2010 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies